FMP
Aclarion, Inc.
ACON
NASDAQ
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
0.337 USD
-0.0557 (-16.53%)
About
ceo
Mr. Brent Ness
sector
Healthcare
industry
Medical - Healthcare Information Services
website
https://www.aclarion.com
exchange
NASDAQ
Description
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
CIK
0001635077
ISIN
US6551872012
CUSIP
655187102
Address
951 Mariners Island Boulevard
Phone
650-241-1741
Country
US
Employee
4
IPO Date
Apr 22, 2022
Key Executives
